Indanone potentiators of metabotropic glutamate receptors

Details for Australian Patent Application No. 2005267883 (hide)

Owner Merck & Co., Inc.

Inventors Kamenecka, Theodore; Vernier, JeanMichel; Hutchinson, John H.; Cube, Rowena V.; Pinkerton, Anthony B.; Bonnefous, Celine

Agent Spruson & Ferguson

Pub. Number AU-A-2005267883

PCT Pub. Number WO2006/015158

Priority 60/592,549 30.07.04 US

Filing date 26 July 2005

Wipo publication date 9 February 2006

International Classifications

C07D 257/04 (2006.01) Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms

Event Publications

22 February 2007 PCT application entered the National Phase

  PCT publication WO2006/015158 Priority application(s): WO2006/015158

24 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005267884-Potassium channel inhibitors

2005267871-Door stop